What happened
Original notice title
Glenn Burkett Naples Corporation MARCS-CMS 613126, January 19, 2022
From the archived source record
Unapproved New and Misbranded Human Drug Products Examples of claims observed on your websites that provide evidence that your products are intended for use as drugs include: On your webpages [see original source] and [see original source] Silver Eye Drops • “SILVER EYE DROPS Anti-Bacterial, Anti-Fungal, Anti-Viral.” Colloidal Silver 1400 ppm Dropper 4 oz • “The Ultimate Silver 1400 ppm is colloidal silver, Anti-Candida(fungal), Bacteria, Virus” • “Dr. Popular heartburn drugs may increase esophageal cancer risk and weaken bones.” Joint Muscle & Back Support • “JOINT MUSCLE & BACK SUPPORT…provide . . . anti-inflammatory . . . Note: Cholesterol, Diabetic, and Blood Pressure medications deplete CoQ10 which could lead to . . . heart, liver or kidney disease, Diabetes, Dementia, Gastrointestinal disorders, and Thyroid problems.” • “Daily108 [included in the Cardiovascular Kit]: . . . Krill Oil • “Krill Oil…aids skin protection against harmful UV rays.” [On your “All Products” Page and “Krill Oil” Product Page] Mellow Life • “This combination formula has several ingredients designed to relieve . . . depression, and anxiety.” On your social media website [see original source] Thyroid Nourishment • “Thyroid Nourishment product on my website GlennBurkett.com Prescription drugs for thyroid causes bone loss osteoporosis” [From September 10, 2020 Facebook Post] Manuka CBD Silver Spray • “Anti-Inflammatory, kills bacteria, viruses, yeast/fungi. A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Colloidal Silver 1400 ppm Dropper, Colloidal Silver 1400 Spray, Silver 750 Sinus Spray, Silver Eye Drops, Daily 108, Daily Detox, Digest Foods Capsule, Mellow Life, Candida Kit, Cardiovascular Kit, and Diabetes Kit fail to bear adequate directions for their intended uses and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)].
What the official notice says to do
Check the original notice for the instructions that apply to the named product, company, and affected lots.
Read the official notice →Status and source details
- Status recorded in the archive
- No closeout listed in FDA table
- Source checked
- Jul 16, 2026
- Record revision
- 25ea6a1ea9a0
This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.
Sources, dates, and coverage →